These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37732455)

  • 21. Health technology assessment of biosimilars worldwide: a scoping review.
    Ascef BO; Lopes ACF; de Soárez PC
    Health Res Policy Syst; 2020 Aug; 18(1):95. PubMed ID: 32843051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stories of Patient Involvement Impact in Health Technology Assessments: A Discussion Paper.
    Single ANV; Facey KM; Livingstone H; Silva AS
    Int J Technol Assess Health Care; 2019; 35(4):266-272. PubMed ID: 31337453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The three-domain impact framework for characterizing impact of patient involvement in health technology assessment.
    Lopez Gousset V; Silveira Silva A; Holtorf AP; Toledo-Chávarri A; Single A
    Int J Technol Assess Health Care; 2024 Nov; 40(1):e52. PubMed ID: 39523886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INTEGRATE-HTA: A LOW- AND MIDDLE-INCOME COUNTRY PERSPECTIVE.
    Bijlmakers L; Mueller D; Kahveci R; Chen Y; van der Wilt GJ
    Int J Technol Assess Health Care; 2017 Jan; 33(5):599-604. PubMed ID: 29103380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for the health technology assessment of complex interventions: a protocol for a scoping review.
    Baghbanian A; Merlin T; Carter D; Wang S
    BMJ Open; 2020 Nov; 10(11):e039263. PubMed ID: 33257482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AN INTEGRATED PERSPECTIVE ON THE ASSESSMENT OF TECHNOLOGIES: INTEGRATE-HTA.
    Wahlster P; Brereton L; Burns J; Hofmann B; Mozygemba K; Oortwijn W; Pfadenhauer L; Polus S; Rehfuess E; Schilling I; van der Wilt GJ; Gerhardus A
    Int J Technol Assess Health Care; 2017 Jan; 33(5):544-551. PubMed ID: 28756780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of stakeholder involvement in the evolving EU HTA process:
    Van Haesendonck L; Ruof J; Desmet T; Van Dyck W; Simoens S; Huys I; Giuliani R; Toumi M; Dierks C; Dierks J; Cardone A; Houÿez F; Pavlovic M; Berntgen M; Mol PGM; Schiel A; Goettsch W; Gianfrate F; Capri S; Ryan J; Ducournau P; Solà-Morales O; Julian E
    J Mark Access Health Policy; 2023; 11(1):2217543. PubMed ID: 37284060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?
    Husereau D; Henshall C; Sampietro-Colom L; Thomas S
    Int J Technol Assess Health Care; 2016 Jan; 32(4):191-199. PubMed ID: 27766998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health technology assessment for sexual reproductive health and rights benefits package design in sub-Saharan Africa: A scoping review of evidence-informed deliberative processes.
    Simangolwa WM; Mbonigaba J; Govender K
    PLoS One; 2024; 19(6):e0306042. PubMed ID: 38935794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introducing patient perspective in health technology assessment at the local level.
    Gagnon MP; Lepage-Savary D; Gagnon J; St-Pierre M; Simard C; Rhainds M; Lemieux R; Gauvin FP; Desmartis M; Légaré F
    BMC Health Serv Res; 2009 Mar; 9():54. PubMed ID: 19327160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can We Afford to Exclude Patients Throughout Health Technology Assessment?
    Wale JL; Chandler D; Collyar D; Hamerlijnck D; Saldana R; Pemberton-Whitely Z
    Front Med Technol; 2021; 3():796344. PubMed ID: 35146487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A situational and stakeholder analysis of health technology assessment in Zimbabwe.
    Dzingirai B; Dambiko P; Matyanga C; Manyau P; Tagwireyi D; Postma MJ; Mafirakureva N; van Hulst M
    Int J Technol Assess Health Care; 2024 Apr; 40(1):e27. PubMed ID: 38679461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.
    Yazdizadeh B; Shahmoradi S; Majdzadeh R; Doaee S; Bazyar M; Souresrafil A; Olyaeemanesh A
    Int J Technol Assess Health Care; 2016 Jan; 32(3):181-9. PubMed ID: 27524462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study.
    van Overbeeke E; Janssens R; Whichello C; Schölin Bywall K; Sharpe J; Nikolenko N; Phillips BS; Guiddi P; Pravettoni G; Vergani L; Marton G; Cleemput I; Simoens S; Kübler J; Juhaeri J; Levitan B; de Bekker-Grob EW; Veldwijk J; Huys I
    Front Pharmacol; 2019; 10():1395. PubMed ID: 31849657
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact assessment of Iran's health technology assessment programme.
    Yazdizadeh B; Mohtasham F; Velayati A
    Health Res Policy Syst; 2018 Feb; 16(1):15. PubMed ID: 29471838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients and public are important stakeholders in health technology assessment but the level of involvement is low - a call to action.
    Wale JL; Thomas S; Hamerlijnck D; Hollander R
    Res Involv Engagem; 2021 Jan; 7(1):1. PubMed ID: 33402216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstrating the influence of HTA: INAHTA member stories of HTA impact.
    Werkö SS; Merlin T; Lambert LJ; Fennessy P; Galán AP; Schuller T
    Int J Technol Assess Health Care; 2020 Nov; 37():e8. PubMed ID: 33148373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient advocate perspectives on involvement in HTA: an international snapshot.
    Scott AM; Wale JL;
    Res Involv Engagem; 2017; 3():2. PubMed ID: 29062527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment.
    Hunter A; Facey K; Thomas V; Haerry D; Warner K; Klingmann I; May M; See W
    Front Med (Lausanne); 2018; 5():231. PubMed ID: 30238004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.